Laura Sepp-Lorenzino

NTLA

Laura Sepp-Lorenzino serves as EVP, Chief Scientific Officer at Intellia Therapeutics, Inc. (NTLA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

7 trades

$19.26M

Net Position

Net Seller

$19.26M

Companies Traded

NTLA

Active Period

Aug 2021 – Jan 2025

7 total trades

Most Recent

Sell NTLA

Jan 7, 2025 · $109.2K

Laura Sepp-Lorenzino's Insider Trading at Intellia Therapeutics, Inc. (NTLA)

Buys

0 · $0.00

Sells

7 · $19.26M

Total Shares Bought

Total Shares Sold

145,759

NTLA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 7, 2025	Sell	8,966	$12.18	$109.2K	77,388
Jan 10, 2024	Sell	2,275	$28.87	$65.7K	44,594
Jan 5, 2024	Sell	5,532	$29.46	$163.0K	46,202
Jan 6, 2023	Sell	4,838	$37.82	$183.0K	19,959
Mar 3, 2022	Sell	1,148	$112.25	$128.9K	4,815
Sep 1, 2021	Sell	97,000	$154.83	$15.02M	83,552
Aug 6, 2021	Sell	26,000	$138.24	$3.59M	26,920